DuPont Bested Q2 Estimates, Top Line Up 19% YoY

July 29, 2011

DuPont (NYSE:DD) reported Q2 EPS of $1.37, ex-items, ahead of consensus estimates of $1.35 per share. Revenues for the quarter rose 19% year-over-year to $10.26 billion, topping consensus estimates of $9.9 billion.The company sees 2011 EPS of $3.90 to $4.05, ex-items, up from $3.65 to $3.85 per share, vs. consensus estimates of $3.84 per share.DuPont Chair and CEO Ellen Kullman said, "Our strong second-quarter sales growth across all segments and regions resulted from consistent global execution and customer-focused innovation. We are increasing our earnings outlook for 2011 based on strong performance year-to-date and confidence in our business plans for the second half of the year. Longer term, we expect additional compelling growth opportunities across our businesses stemming from science-powered innovations and collaboration, including the integration of Danisco's world-class enzymes, fermentation and specialty food ingredients capabilities with DuPont's strong industrial biosciences and nutrition & health offerings."